当前位置:首页 - 行情中心 - 德源药业(832735) - 财务分析 - 现金流量表

德源药业

(832735)

  

流通市值:40.53亿  总市值:45.82亿
流通股本:1.04亿   总股本:1.17亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金494,325,261.84246,429,650.94811,278,048.4599,443,775.13
  收到的税费返还3,229,766.95-3,649,201.773,649,201.77
  收到其他与经营活动有关的现金5,526,885.681,337,274.2352,901,636.220,048,083.55
  经营活动现金流入小计503,081,914.47247,766,925.17867,828,886.37623,141,060.45
  购买商品、接受劳务支付的现金71,056,197.0638,980,557.3687,393,796.6953,022,103.8
  支付给职工以及为职工支付的现金96,966,170.0453,986,562149,923,905.45111,189,658.53
  支付的各项税费77,457,079.6133,500,120.65114,795,41376,637,328.78
  支付其他与经营活动有关的现金228,460,653.08105,743,189.77399,393,750.26296,038,953.5
  经营活动现金流出小计473,940,099.79232,210,429.78751,506,865.4536,888,044.61
  经营活动产生的现金流量净额29,141,814.6815,556,495.39116,322,020.9786,253,015.84
二、投资活动产生的现金流量:
  取得投资收益收到的现金2,982,726.1660,544.514,308,845.732,457,628.73
  处置固定资产、无形资产和其他长期资产收回的现金净额9,624.03-34,216.3934,216.39
  收到的其他与投资活动有关的现金1,082,600,000341,000,0001,966,800,000986,800,000
  投资活动现金流入小计1,085,592,350.13341,660,544.511,971,143,062.12989,291,845.12
  购建固定资产、无形资产和其他长期资产支付的现金19,122,192.229,200,804.2233,973,866.1425,450,827.18
  支付其他与投资活动有关的现金1,172,798,250482,698,2502,161,955,333.331,161,955,333.33
  投资活动现金流出小计1,191,920,442.22491,899,054.222,195,929,199.471,187,406,160.51
  投资活动产生的现金流量净额-106,328,092.09-150,238,509.71-224,786,137.35-198,114,315.39
三、筹资活动产生的现金流量:
  取得借款收到的现金--27,090,00027,090,000
  筹资活动现金流入平衡项目--00
  筹资活动现金流入小计--27,090,00027,090,000
  偿还债务支付的现金12,590,000-26,500,00026,500,000
  分配股利、利润或偿付利息支付的现金36,349,808.13187,339.9928,925,509.5528,736,088.01
  支付其他与筹资活动有关的现金--1,202,569.79901,401
  筹资活动现金流出小计48,939,808.13187,339.9956,628,079.3456,137,489.01
  筹资活动产生的现金流量净额-48,939,808.13-187,339.99-29,538,079.34-29,047,489.01
五、现金及现金等价物净增加额-126,126,085.54-134,869,354.31-138,002,195.72-140,908,788.56
  加:期初现金及现金等价物余额303,978,604.29303,978,604.29441,980,800.01441,980,800.01
  期末现金及现金等价物余额177,852,518.75169,109,249.98303,978,604.29301,072,011.45
补充资料:
  净利润97,785,465-176,983,423.5-
  资产减值准备1,181,992.82---
  固定资产和投资性房地产折旧13,072,590.29-25,575,664.49-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧13,072,590.29-25,575,664.49-
  无形资产摊销436,750.44-1,500,092.82-
  长期待摊费用摊销159,329.02-121,201.49-
  固定资产报废损失85,121.41-46,697.53-
  公允价值变动损失-386,739.73--66,684.93-
  财务费用383,823.25-799,771.22-
  投资损失-4,210,615.76--4,739,100.37-
  递延所得税-140,446.1--2,762,794.33-
  其中:递延所得税资产减少-66,510.42--3,002,309.5-
    递延所得税负债增加-73,935.68-239,515.17-
  存货的减少-943,905.42--7,671,115.9-
  经营性应收项目的减少-102,912,402.98--145,941,362.48-
  经营性应付项目的增加23,334,268.48-70,945,374.75-
  其他--725,470.13-
  现金的期末余额177,852,518.75-303,978,604.29-
  减:现金的期初余额303,978,604.29-441,980,800.01-
  现金及现金等价物的净增加额-126,126,085.54--138,002,195.72-
公告日期2025-08-192025-04-282025-03-312024-10-25
审计意见(境内)标准无保留意见
TOP↑